1. Home
  2. ACHV vs LSE Comparison

ACHV vs LSE Comparison

Compare ACHV & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • LSE
  • Stock Information
  • Founded
  • ACHV N/A
  • LSE 2007
  • Country
  • ACHV United States
  • LSE China
  • Employees
  • ACHV N/A
  • LSE N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LSE Metal Fabrications
  • Sector
  • ACHV Health Care
  • LSE Industrials
  • Exchange
  • ACHV Nasdaq
  • LSE Nasdaq
  • Market Cap
  • ACHV 72.5M
  • LSE 85.6M
  • IPO Year
  • ACHV N/A
  • LSE 2024
  • Fundamental
  • Price
  • ACHV $2.26
  • LSE $5.54
  • Analyst Decision
  • ACHV Strong Buy
  • LSE
  • Analyst Count
  • ACHV 3
  • LSE 0
  • Target Price
  • ACHV $14.33
  • LSE N/A
  • AVG Volume (30 Days)
  • ACHV 1.2M
  • LSE 1.4M
  • Earning Date
  • ACHV 08-12-2025
  • LSE 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • LSE N/A
  • EPS Growth
  • ACHV N/A
  • LSE N/A
  • EPS
  • ACHV N/A
  • LSE 0.52
  • Revenue
  • ACHV N/A
  • LSE $69,073,374.00
  • Revenue This Year
  • ACHV N/A
  • LSE N/A
  • Revenue Next Year
  • ACHV N/A
  • LSE N/A
  • P/E Ratio
  • ACHV N/A
  • LSE $10.42
  • Revenue Growth
  • ACHV N/A
  • LSE N/A
  • 52 Week Low
  • ACHV $1.84
  • LSE $3.76
  • 52 Week High
  • ACHV $5.31
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 35.12
  • LSE N/A
  • Support Level
  • ACHV $2.00
  • LSE N/A
  • Resistance Level
  • ACHV $3.90
  • LSE N/A
  • Average True Range (ATR)
  • ACHV 0.28
  • LSE 0.00
  • MACD
  • ACHV -0.18
  • LSE 0.00
  • Stochastic Oscillator
  • ACHV 13.68
  • LSE 0.00

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: